Pohang, South Korea

Jong-Su Jeon

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Novmetapharma Co., Ltd.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong-Su Jeon. Retrieved from https://idiyas.com/inventor/jong-su-jeon-0pn5q305

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jong-Su Jeon in Cell Protection

Introduction

Jong-Su Jeon is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of cell protection, particularly concerning kidney and liver health. With a total of three patents to his name, his work focuses on innovative compositions that utilize cyclo histidine-proline as an active ingredient.

Latest Patents

Jong-Su Jeon's latest patents include a cell-protecting composition that contains cyclo histidine-proline (Cyclo His-Pro, CHP) as an active ingredient. This composition has demonstrated an excellent protective effect against damage and toxicity to kidney and liver cells caused by various factors. The innovative formulation is particularly useful in treating subjects with kidney and liver diseases or damages. Another patent highlights a similar composition for cell protection, emphasizing the effectiveness of cyclo histidine-proline in safeguarding these vital organs.

Career Highlights

Jong-Su Jeon is currently associated with Novmetapharma Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in medical treatments and therapies aimed at improving organ health.

Collaborations

Some of his notable coworkers include Hoe-Yune Jung and Heon-Jong Lee, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Jong-Su Jeon's innovative work in cell protection showcases the potential of cyclo histidine-proline in medical applications. His contributions are paving the way for advancements in treatments for kidney and liver diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…